?

Thompson Craig B.

Director
Regeneron Pharmaceuticals, Inc.
US, Tarrytown [HQ]
CIK 1423419

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
620
Price per Share :
$703.43
Equivalence :
$436,126.60

Transaction History

  • A
    Form 4
    620 Shares After Transaction
    Value : $n/a
    $0.0
    01/02/25
  • Footnotes:
    #1 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.